The ASPIRE Trial - Aiming for Safe Pregnancies by Reducing Malaria and Infections of the Reproductive Tract

NCT04189744 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

5436

Enrollment

OTHER

Sponsor class

Conditions

Pregnancy Malaria
Bacterial Vaginoses
Trichomonas Vaginitis

Interventions

DRUG: IPTp-sulphadoxine-pyrimethamine plus metronidazole
DRUG: IPTp-dihydroartemisinin-piperaquine plus metronidazole
DRUG: IPTp-sulphadoxine-pyrimethamine

Sponsor

London School of Hygiene and Tropical Medicine